GLP-1 Loading During Elective Percutaneous Coronary Intervention
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 193 participants.
Also called NCT02127996
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 193 participants
- Registry
-
NCT02127996
-
- Other papers using this trial's data
- The role of Glucagon-Like Peptide 1 Loading on periprocedural myocardial infarction During elective PCI (GOLD-PCI study): A randomized, placebo-controlled trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Unknown status
Technical summary
Registry record NCT02127996. Randomized; quadruple masking; primary purpose treatment. Start 2015-03 (registry gives no type); primary completion 2017-03-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- GLP-1 Loading During Elective Percutaneous Coronary Intervention
- Acronym
- GOLD-PCI
- Condition
- Angina Pectoris
- Condition
- Myocardial Infarction
- Condition
- Reperfusion Injury
- Condition
- Coronary Heart Disease
- Intervention (Drug)
- GLP-1
- Intervention (Drug)
- placebo
- Lead sponsor
- Papworth Hospital NHS Foundation Trust
Record details
- Record id
cardio:ct-nct02127996- Content hash
9724fdcf100addb7cb4957f5f1204dfb441ad0c0d055b52c2e1615cea24acf1d